You are here

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Hypothesis
T follicular helper cells: linking cancer immunotherapy and immune-related adverse events

Authors

  • Dirk Baumjohann Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Bonn, Germany PubMed articlesGoogle scholar articles
  • Peter Brossart Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Bonn, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Dirk Baumjohann; dirk.baumjohann{at}uni-bonn.de
View Full Text

Citation

Baumjohann D, Brossart P
T follicular helper cells: linking cancer immunotherapy and immune-related adverse events
Journal for ImmunoTherapy of Cancer 2021;9:e002588. doi: 10.1136/jitc-2021-002588

Publication history

  • Accepted May 19, 2021
  • First published June 10, 2021.
Online issue publication 
February 24, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.